{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:44:10Z","timestamp":1791193450176,"version":"4.1.0"},"reference-count":61,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1681\/asn.2013070810","type":"journal-article","created":{"date-parts":[[2014,2,8]],"date-time":"2014-02-08T02:51:56Z","timestamp":1391827916000},"page":"1237-1254","source":"Crossref","is-referenced-by-count":333,"title":["Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy"],"prefix":"10.1681","volume":"25","author":[{"given":"Jay C.","family":"Jha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen P.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Barit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assam","family":"El-Osta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamehachi","family":"Namikoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicki","family":"Thallas-Bonke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirstin","family":"Wingler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Szyndralewiez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freddy","family":"Heitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhian M.","family":"Touyz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald H.H.W.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin A.","family":"Jandeleit-Dahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-15-20230208","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.2337\/diacare.27.2007.S79","article-title":"Nephropathy in diabetes.","volume":"27","author":"Molitch","year":"2004","journal-title":"Diabetes Care"},{"key":"R2-15-20230208","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/nrd2476","article-title":"Therapies for hyperglycaemia-induced diabetic complications: From animal models to clinical trials.","volume":"8","author":"Calcutt","year":"2009","journal-title":"Nat Rev Drug Discov"},{"key":"R3-15-20230208","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00281-008-0122-7","article-title":"NOX enzymes and diabetic complications.","volume":"30","author":"Kakehi","year":"2008","journal-title":"Semin Immunopathol"},{"key":"R4-15-20230208","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.2337\/diabetes.52.10.2603","article-title":"Translocation of glomerular p47phox and p67phox by protein kinase C-beta activation is required for oxidative stress in diabetic nephropathy.","volume":"52","author":"Kitada","year":"2003","journal-title":"Diabetes"},{"key":"R5-15-20230208","doi-asserted-by":"crossref","first-page":"F1144","DOI":"10.1152\/ajprenal.00221.2004","article-title":"NAD(P)H oxidase and uncoupled nitric oxide synthase are major sources of glomerular superoxide in rats with experimental diabetic nephropathy.","volume":"288","author":"Satoh","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"R6-15-20230208","doi-asserted-by":"crossref","first-page":"225","DOI":"10.2337\/diabetes.55.01.06.db05-0894","article-title":"Glucose-induced reactive oxygen species cause apoptosis of podocytes and podocyte depletion at the onset of diabetic nephropathy.","volume":"55","author":"Susztak","year":"2006","journal-title":"Diabetes"},{"key":"R7-15-20230208","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1097\/MNH.0b013e32832923c3","article-title":"Molecular mechanisms of hypertension: Role of Nox family NADPH oxidases.","volume":"18","author":"Sedeek","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R8-15-20230208","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/CS20120330","article-title":"Renoprotective effects of a novel Nox1\/4 inhibitor in a mouse model of Type 2 diabetes.","volume":"124","author":"Sedeek","year":"2013","journal-title":"Clin Sci (Lond"},{"key":"R9-15-20230208","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.pharmthera.2008.08.005","article-title":"NADPH oxidases in the vasculature: Molecular features, roles in disease and pharmacological inhibition.","volume":"120","author":"Selemidis","year":"2008","journal-title":"Pharmacol Ther"},{"key":"R10-15-20230208","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1476-5381.2011.01249.x","article-title":"NOX1, 2, 4, 5: Counting out oxidative stress.","volume":"164","author":"Wingler","year":"2011","journal-title":"Br J Pharmacol"},{"key":"R11-15-20230208","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1007\/s00125-003-1205-6","article-title":"Increased expression of NAD(P)H oxidase subunits, NOX4 and p22phox, in the kidney of streptozotocin-induced diabetic rats and its reversibity by interventive insulin treatment.","volume":"46","author":"Etoh","year":"2003","journal-title":"Diabetologia"},{"key":"R12-15-20230208","doi-asserted-by":"crossref","first-page":"F528","DOI":"10.1152\/ajprenal.00127.2010","article-title":"The pleiotropic actions of rosuvastatin confer renal benefits in the diabetic Apo-E knockout mouse.","volume":"299","author":"Giunti","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"R13-15-20230208","doi-asserted-by":"crossref","first-page":"3112","DOI":"10.2337\/db06-0895","article-title":"Reduction of diabetes-induced oxidative stress, fibrotic cytokine expression, and renal dysfunction in protein kinase Cbeta-null mice.","volume":"55","author":"Ohshiro","year":"2006","journal-title":"Diabetes"},{"key":"R14-15-20230208","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.112.132159","article-title":"NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis.","volume":"127","author":"Gray","year":"2013","journal-title":"Circulation"},{"key":"R15-15-20230208","doi-asserted-by":"crossref","first-page":"14385","DOI":"10.1073\/pnas.0906805106","article-title":"Subcellular localization of Nox4 and regulation in diabetes.","volume":"106","author":"Block","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-15-20230208","doi-asserted-by":"crossref","first-page":"8010","DOI":"10.1073\/pnas.130135897","article-title":"Identification of renox, an NAD(P)H oxidase in kidney.","volume":"97","author":"Geiszt","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R17-15-20230208","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2013.03.014","article-title":"Nox4 and diabetic nephropathy: With a friend like this, who needs enemies?","volume":"61C","author":"Gorin","year":"2013","journal-title":"Free Radic Biol Med"},{"key":"R18-15-20230208","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1074\/jbc.M007597200","article-title":"A novel superoxide-producing NAD(P)H oxidase in kidney.","volume":"276","author":"Shiose","year":"2001","journal-title":"J Biol Chem"},{"key":"R19-15-20230208","doi-asserted-by":"crossref","first-page":"39616","DOI":"10.1074\/jbc.M502412200","article-title":"Nox4 NAD(P)H oxidase mediates hypertrophy and fibronectin expression in the diabetic kidney.","volume":"280","author":"Gorin","year":"2005","journal-title":"J Biol Chem"},{"key":"R20-15-20230208","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.freeradbiomed.2012.06.027","article-title":"Role of Nox4 in murine models of kidney disease.","volume":"53","author":"Babelova","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"R21-15-20230208","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1681\/ASN.2012040373","article-title":"NADPH-oxidase 4 protects against kidney fibrosis during chronic renal injury.","volume":"23","author":"Nlandu Khodo","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R22-15-20230208","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1002\/hep.25938","article-title":"Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.","volume":"56","author":"Aoyama","year":"2012","journal-title":"Hepatology"},{"key":"R23-15-20230208","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.2337\/diabetes.48.11.2229","article-title":"Increased renal expression of vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 in experimental diabetes.","volume":"48","author":"Cooper","year":"1999","journal-title":"Diabetes"},{"key":"R24-15-20230208","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S0076-6879(08)01213-5","article-title":"Assessment of superoxide production and NADPH oxidase activity by HPLC analysis of dihydroethidium oxidation products.","volume":"441","author":"Laurindo","year":"2008","journal-title":"Methods Enzymol"},{"key":"R25-15-20230208","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/sj.ki.5000014","article-title":"Monocyte chemoattractant protein-1 promotes the development of diabetic renal injury in streptozotocin-treated mice.","volume":"69","author":"Chow","year":"2006","journal-title":"Kidney Int"},{"key":"R26-15-20230208","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1053\/snep.2002.34724","article-title":"Role of nephrin in renal disease including diabetic nephropathy.","volume":"22","author":"Cooper","year":"2002","journal-title":"Semin Nephrol"},{"key":"R27-15-20230208","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2337\/db10-1110","article-title":"Dedifferentiation of immortalized human podocytes in response to transforming growth factor-\u03b2: A model for diabetic podocytopathy.","volume":"60","author":"Herman-Edelstein","year":"2011","journal-title":"Diabetes"},{"key":"R28-15-20230208","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1681\/ASN.2013010060","article-title":"Genetic deletion of CDA1 retards diabetes associated renal injury.","volume":"24","author":"Chai","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R29-15-20230208","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/01.ASN.0000133025.23732.46","article-title":"Accelerated nephropathy in diabetic apolipoprotein e-knockout mouse: Role of advanced glycation end products.","volume":"15","author":"Lassila","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R30-15-20230208","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s00018-012-1010-9","article-title":"The NOX toolbox: Validating the role of NADPH oxidases in physiology and disease.","volume":"69","author":"Altenh\u00f6fer","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"R31-15-20230208","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/j.1476-5381.2010.00920.x","article-title":"Comparative pharmacology of chemically distinct NADPH oxidase inhibitors.","volume":"161","author":"Wind","year":"2010","journal-title":"Br J Pharmacol"},{"key":"R32-15-20230208","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/sj.ki.5002366","article-title":"Pitavastatin ameliorates albuminuria and renal mesangial expansion by downregulating NOX4 in db\/db mice.","volume":"72","author":"Fujii","year":"2007","journal-title":"Kidney Int"},{"key":"R33-15-20230208","doi-asserted-by":"crossref","first-page":"F323","DOI":"10.1152\/ajprenal.00522.2012","article-title":"ADAM17 mediates Nox4 expression and NADPH oxidase activity in the kidney cortex of OVE26 mice.","volume":"305","author":"Ford","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"R34-15-20230208","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/ki.2010.199","article-title":"Susceptible mice: Identifying a diabetic nephropathy disease locus using a murine model.","volume":"78","author":"Brosius","year":"2010","journal-title":"Kidney Int"},{"key":"R35-15-20230208","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1681\/ASN.2009020146","article-title":"NAD(P)H oxidase mediates TGF-beta1-induced activation of kidney myofibroblasts.","volume":"21","author":"Bondi","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R36-15-20230208","doi-asserted-by":"crossref","first-page":"F1348","DOI":"10.1152\/ajprenal.00028.2010","article-title":"Critical role of Nox4-based NADPH oxidase in glucose-induced oxidative stress in the kidney: Implications in type 2 diabetic nephropathy.","volume":"299","author":"Sedeek","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"R37-15-20230208","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1002\/jcb.23088","article-title":"High glucose concentration affects the oxidant-antioxidant balance in cultured mouse podocytes.","volume":"112","author":"Piwkowska","year":"2011","journal-title":"J Cell Biochem"},{"key":"R38-15-20230208","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.2337\/diabetes.51.10.3090","article-title":"Amelioration of long-term renal changes in obese type 2 diabetic mice by a neutralizing vascular endothelial growth factor antibody.","volume":"51","author":"Flyvbjerg","year":"2002","journal-title":"Diabetes"},{"key":"R39-15-20230208","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.2337\/db09-1057","article-title":"Inhibition of reactive oxygen species by Lovastatin downregulates vascular endothelial growth factor expression and ameliorates blood-retinal barrier breakdown in db\/db mice: Role of NADPH oxidase 4.","volume":"59","author":"Li","year":"2010","journal-title":"Diabetes"},{"key":"R40-15-20230208","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1371\/journal.pbio.1000479","article-title":"Post-stroke inhibition of induced NADPH oxidase type 4 prevents oxidative stress and neurodegeneration.","volume":"8","author":"Kleinschnitz","year":"2010","journal-title":"PLoS Biol"},{"key":"R41-15-20230208","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.cardiores.2006.09.012","article-title":"Role of NADPH oxidase 4 in lipopolysaccharide-induced proinflammatory responses by human aortic endothelial cells.","volume":"72","author":"Park","year":"2006","journal-title":"Cardiovasc Res"},{"key":"R42-15-20230208","doi-asserted-by":"crossref","first-page":"2570","DOI":"10.2337\/diabetes.52.10.2570","article-title":"Reactive oxygen species from mitochondria induce cyclooxygenase-2 gene expression in human mesangial cells: Potential role in diabetic nephropathy.","volume":"52","author":"Kiritoshi","year":"2003","journal-title":"Diabetes"},{"key":"R43-15-20230208","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/35008121","article-title":"Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage.","volume":"404","author":"Nishikawa","year":"2000","journal-title":"Nature"},{"key":"R44-15-20230208","doi-asserted-by":"crossref","first-page":"R117","DOI":"10.1152\/ajpregu.00476.2002","article-title":"Effects of ANG II type 1 and 2 receptors on oxidative stress, renal NADPH oxidase, and SOD expression.","volume":"285","author":"Chabrashvili","year":"2003","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"R45-15-20230208","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/01.ASN.0000108523.02100.E0","article-title":"The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt-sensitive rats.","volume":"15","author":"Nishiyama","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R46-15-20230208","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.semnephrol.2007.01.009","article-title":"The renin-angiotensin system and diabetic nephropathy.","volume":"27","author":"Gurley","year":"2007","journal-title":"Semin Nephrol"},{"key":"R47-15-20230208","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2310\/JIM.0b013e31827c28bb","article-title":"Cardinal role of the intrarenal renin-angiotensin system in the pathogenesis of diabetic nephropathy.","volume":"61","author":"Kobori","year":"2013","journal-title":"J Investig Med"},{"key":"R48-15-20230208","doi-asserted-by":"crossref","first-page":"H282","DOI":"10.1152\/ajpheart.00231.2012","article-title":"Angiotensin II enhances AT1-Nox1 binding and stimulates arterial smooth muscle cell migration and proliferation through AT1, Nox1, and interleukin-18.","volume":"303","author":"Valente","year":"2012","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R49-15-20230208","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1161\/CIRCULATIONAHA.113.002564","article-title":"Knock, knock: Who\u2019s there?: Nox1.","volume":"127","author":"Itani","year":"2013","journal-title":"Circulation"},{"key":"R50-15-20230208","doi-asserted-by":"crossref","first-page":"F840","DOI":"10.1152\/ajprenal.00511.2012","article-title":"Role of Nox2 in diabetic kidney disease.","volume":"304","author":"You","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"R51-15-20230208","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s12265-012-9387-2","article-title":"Oxidative stress, Nox isoforms and complications of diabetes\u2014potential targets for novel therapies.","volume":"5","author":"Sedeek","year":"2012","journal-title":"J Cardiovasc Transl Res"},{"key":"R52-15-20230208","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.freeradbiomed.2012.05.007","article-title":"Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4\/NOX1 inhibitor in vivo.","volume":"53","author":"Jiang","year":"2012","journal-title":"Free Radic Biol Med"},{"key":"R53-15-20230208","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.febslet.2005.12.049","article-title":"Decreased blood pressure in NOX1-deficient mice.","volume":"580","author":"Gavazzi","year":"2006","journal-title":"FEBS Lett"},{"key":"R54-15-20230208","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.atherosclerosis.2011.02.028","article-title":"Role for Nox1 NADPH oxidase in atherosclerosis.","volume":"216","author":"Sheehan","year":"2011","journal-title":"Atherosclerosis"},{"key":"R55-15-20230208","doi-asserted-by":"crossref","first-page":"7715","DOI":"10.1021\/jm100773e","article-title":"First in class, potent, and orally bioavailable NADPH oxidase isoform 4 (Nox4) inhibitors for the treatment of idiopathic pulmonary fibrosis.","volume":"53","author":"Laleu","year":"2010","journal-title":"J Med Chem"},{"key":"R56-15-20230208","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1007\/s00125-009-1540-3","article-title":"The endothelin receptor antagonist avosentan ameliorates nephropathy and atherosclerosis in diabetic apolipoprotein E knockout mice.","volume":"53","author":"Watson","year":"2010","journal-title":"Diabetologia"},{"key":"R57-15-20230208","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1161\/01.HYP.25.5.1111","article-title":"A noninvasive computerized tail-cuff system for measuring blood pressure in mice.","volume":"25","author":"Krege","year":"1995","journal-title":"Hypertension"},{"key":"R58-15-20230208","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.2337\/db11-1546","article-title":"Alagebrium reduces glomerular fibrogenesis and inflammation beyond preventing RAGE activation in diabetic apolipoprotein E knockout mice.","volume":"61","author":"Watson","year":"2012","journal-title":"Diabetes"},{"key":"R59-15-20230208","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/ndt\/gfl212","article-title":"PPAR-alpha and -gamma agonists attenuate diabetic kidney disease in the apolipoprotein E knockout mouse.","volume":"21","author":"Calkin","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R60-15-20230208","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1681\/ASN.V133630","article-title":"A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression.","volume":"13","author":"Saleem","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R61-15-20230208","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1161\/CIRCRESAHA.112.266171","article-title":"Distinguishing hyperglycemic changes by Set7 in vascular endothelial cells.","volume":"110","author":"Okabe","year":"2012","journal-title":"Circ Res"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201406000-00015","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:23:49Z","timestamp":1786130629000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201406000-00015"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6]]},"references-count":61,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2013070810","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2014,6]]}}}